Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Solomon

Showing results (461-470 of 524) with videos related to

Pageof 53
Sort By:
RMD Open|September 5, 2024
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trialsKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
American Heart Journal|April 1, 2009
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trialWilliam H Shrank, Niteesh K Choudhry, Daniel H Solomon, et al.
Seminars in Arthritis and Rheumatism|March 13, 2017
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) StudyJeffrey A Sparks, Medha Barbhaiya, Elizabeth W Karlson, et al.
Annals of the Rheumatic Diseases|October 14, 2011
Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohortSiri Lillegraven, Femke H M Prince, Nancy A Shadick, et al.
BMJ (Clinical Research Ed.)|April 18, 2023
Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort studyHouchen Lyu, Sizheng Steven Zhao, Licheng Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2025
Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause: Interrupted Time-Series AnalysesShreya Billa, Sho Fukui, Misti L Paudel, et al.
Clinical Endocrinology|April 12, 2019
Temporal increases in 25-hydroxyvitamin D in midlife women: Longitudinal results from the Study of Women's Health Across the NationDeborah M Mitchell, Kristin Ruppert, Nisha Udupa, et al.
Medical Care|August 4, 2009
An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomesWilliam H Shrank, Amanda Patrick, Patrick P Gleason, et al.
The Lancet. Rheumatology|April 25, 2026
Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort studySho Fukui, Hilde S Ørbo, Sara K Tedeschi, et al.
Arthritis Care & Research|July 23, 2014
Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplastyElena Losina, A David Paltiel, Alexander M Weinstein, et al.
Pageof 53

Showing results (461-470 of 524) with videos related to

Sort By:
Pageof 53
RMD Open|September 5, 2024
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trialsKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
American Heart Journal|April 1, 2009
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trialWilliam H Shrank, Niteesh K Choudhry, Daniel H Solomon, et al.
Seminars in Arthritis and Rheumatism|March 13, 2017
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) StudyJeffrey A Sparks, Medha Barbhaiya, Elizabeth W Karlson, et al.
Annals of the Rheumatic Diseases|October 14, 2011
Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohortSiri Lillegraven, Femke H M Prince, Nancy A Shadick, et al.
BMJ (Clinical Research Ed.)|April 18, 2023
Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort studyHouchen Lyu, Sizheng Steven Zhao, Licheng Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2025
Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause: Interrupted Time-Series AnalysesShreya Billa, Sho Fukui, Misti L Paudel, et al.
Clinical Endocrinology|April 12, 2019
Temporal increases in 25-hydroxyvitamin D in midlife women: Longitudinal results from the Study of Women's Health Across the NationDeborah M Mitchell, Kristin Ruppert, Nisha Udupa, et al.
Medical Care|August 4, 2009
An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomesWilliam H Shrank, Amanda Patrick, Patrick P Gleason, et al.
The Lancet. Rheumatology|April 25, 2026
Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort studySho Fukui, Hilde S Ørbo, Sara K Tedeschi, et al.
Arthritis Care & Research|July 23, 2014
Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplastyElena Losina, A David Paltiel, Alexander M Weinstein, et al.
Pageof 53